Itau Unibanco Holding S.A.’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-618
Closed -$7K 1030
2019
Q3
$7K Hold
618
﹤0.01% 288
2019
Q2
$7K Buy
+618
New +$7.48K ﹤0.01% 592
2018
Q3
Sell
-2,705
Closed -$43K 840
2018
Q2
$43K Sell
2,705
-727
-21% -$11K ﹤0.01% 632
2018
Q1
$44K Buy
3,432
+2,438
+245% +$35.3K ﹤0.01% 490
2017
Q4
$11K Buy
994
+121
+14% +$1.35K ﹤0.01% 521
2017
Q3
$34K Buy
+873
New +$9.1K ﹤0.01% 603

Itau Unibanco Holding S.A.'s ALDR Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 618 shares — an estimated $7K sold.

Itau Unibanco Holding S.A. first reported a position in ALDR in Q3 2017 and held it in 6 quarters. The position peaked at $44K in Q1 2018. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 618 Alder Biopharmaceuticals shares in Q4 2019, an estimated $7K.
  • Itau Unibanco Holding S.A. first reported a position in Alder Biopharmaceuticals in Q3 2017 and held it in 6 quarters.
  • Itau Unibanco Holding S.A.'s Alder Biopharmaceuticals position peaked at $44K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.